arrow
B

Brandon A. Mahal

sylvester comprehensive cancer center
H指数:46
被引数:7,042

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interpretable machine learning identifies health system levers for survival outcomes of patients with prostate cancer

可解释机器学习识别影响前列腺癌患者生存结果的健康系统杠杆

2026-10-020
PRE
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)

PAM50分类器在主动监测中预测前列腺癌进展的验证分析:迈阿密主动监测试验(MAST)

2026-02-270
OAAI
Metabolomic Insights Into Saliva as a Non-Invasive Surrogate for Serum to Enable Community-Based Biomarker Investigation

唾液代谢组学洞察:作为血清非侵入性替代品以实现社区基础生物标志物研究

2026-02-010
OAAI
Factors associated with prostate cancer screening among Hispanic men: Results from the Hispanic Community Health Study/Study of Latinos

与拉丁裔男性前列腺癌筛查相关的因素:来自拉丁裔社区健康研究/拉丁裔研究的结果

Cancer
IF5.1
2025-08-070
OAAI
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score

独立于临床信息和PIRADS评分评估4kscore在预测前列腺癌主动监测进展中的作用

2024-09-270
PRE
Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers
2024-09-101
PRE